Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
24 participants
INTERVENTIONAL
2025-01-15
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIV
NCT00602758
Specialized Cognitive-Behavioral Counseling Intervention to Reduce HIV Transmission Risk Behavior in HIV-Infected Men
NCT00218712
Intervention to Improve Engagement in Care Among Newly Diagnosed HIV-positive Men
NCT01559805
Group Psychotherapy for People With HIV
NCT00186550
Body Image and Self-Care in HIV-Infected MSM
NCT01817621
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acceptance and commitment therapy
Trial of acceptance and commitment therapy for hiv-positive men.
Acceptance and commitment therapy
Acceptance and commitment therapy is a psychotherapy focused at increasing psychological flexibility and an individual\'s engagement in valued activities rather than focusing solely or primarily on reducing psychiatric symptoms
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acceptance and commitment therapy
Acceptance and commitment therapy is a psychotherapy focused at increasing psychological flexibility and an individual\'s engagement in valued activities rather than focusing solely or primarily on reducing psychiatric symptoms
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be at least 18 years old
* has been diagnosed with HIV by a healthcare professional
Exclusion Criteria
* has attempted suicide within the last year
* has had an active plan to attempt suicide within the last 30 days
* is currently diagnosed with any eating disorder
* has experienced hallucinations or delusions within the last 30 days
* has used narcotics within the last 7 days (heroin, meth, crack cocaine, opioids)
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nicholas C. Borgogna
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicholas Borgogna, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Drew Whittington, MS, MA
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Start-up
Identifier Type: OTHER
Identifier Source: secondary_id
IRB-300013506
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.